Strumento inattivo

Azioni Biondvax Pharmaceuticals Ltd Other OTC

Azioni

Durata

Periodo

Stile

Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million	16/07/19
Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial	08/07/19
Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million	26/06/19
Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan	18/06/19
Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process	10/06/19

Settore

	Variaz. 1 gen.	Capi.
MODERNA, INC.	+42,79%	50,93 Mrd
IQVIA HOLDINGS INC.	-0,49%	42,12 Mrd
LONZA GROUP AG	+49,62%	42,05 Mrd
CELLTRION, INC.	-7,20%	29,18 Mrd
ICON PUBLIC LIMITED COMPANY	+12,82%	26,02 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-21,80%	18,9 Mrd
BIO-TECHNE CORPORATION	+7,56%	13,21 Mrd
UNITED THERAPEUTICS CORPORATION	+24,21%	12,17 Mrd
MEDPACE HOLDINGS, INC.	+29,99%	12,16 Mrd